170 related articles for article (PubMed ID: 29165288)
21. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
[TBL] [Abstract][Full Text] [Related]
22. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
23. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
[TBL] [Abstract][Full Text] [Related]
24. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
25. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets.
Zhu X; Lazow MA; Schafer A; Bartlett A; Senthil Kumar S; Mishra DK; Dexheimer P; DeWire M; Fuller C; Leach JL; Fouladi M; Drissi R
Acta Neuropathol Commun; 2021 Jan; 9(1):14. PubMed ID: 33431066
[TBL] [Abstract][Full Text] [Related]
26. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
Poussaint TY; Kocak M; Vajapeyam S; Packer RI; Robertson RL; Geyer R; Haas-Kogan D; Pollack IF; Vezina G; Zimmerman R; Cha S; Patay Z; Boyett JM; Kun LE
Neuro Oncol; 2011 Apr; 13(4):417-27. PubMed ID: 21297126
[TBL] [Abstract][Full Text] [Related]
27. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.
Fields EC; Damek D; Gaspar LE; Liu AK; Kavanagh BD; Waziri A; Lillehei K; Chen C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):51-7. PubMed ID: 21035955
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
[TBL] [Abstract][Full Text] [Related]
29. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of
Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
[TBL] [Abstract][Full Text] [Related]
31. Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma.
Ko C; Kaushal A; Hammoud DA; Steffen-Smith EA; Bent R; Citrin D; Camphausen K; Warren KE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1252-1256. PubMed ID: 22280788
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of conformal radiation therapy for pediatric low-grade glioma.
Merchant TE; Kun LE; Wu S; Xiong X; Sanford RA; Boop FA
J Clin Oncol; 2009 Aug; 27(22):3598-604. PubMed ID: 19581536
[TBL] [Abstract][Full Text] [Related]
33. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
Fried I; Lossos A; Ben Ami T; Dvir R; Toledano H; Ben Arush MW; Postovski S; Abu Kuidar A; Yalon M; Weintraub M; Benifla M
J Neurooncol; 2018 Jan; 136(1):189-195. PubMed ID: 29143272
[TBL] [Abstract][Full Text] [Related]
34. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
J Neurosurg Pediatr; 2021 Aug; 28(4):371-379. PubMed ID: 34359048
[TBL] [Abstract][Full Text] [Related]
35. A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.
Singh R; Zhou Z; Tisnado J; Haque S; Peck KK; Young RJ; Tsiouris AJ; Thakur SB; Souweidane MM
J Neurosurg Pediatr; 2016 Nov; 18(5):565-572. PubMed ID: 27391980
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.
Zaghloul MS; Eldebawy E; Ahmed S; Mousa AG; Amin A; Refaat A; Zaky I; Elkhateeb N; Sabry M
Radiother Oncol; 2014 Apr; 111(1):35-40. PubMed ID: 24560760
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
Haas-Kogan DA; Banerjee A; Kocak M; Prados MD; Geyer JR; Fouladi M; McKnight T; Poussaint TY; Broniscer A; Blaney SM; Boyett JM; Kun LE
Neuro Oncol; 2008 Jun; 10(3):341-7. PubMed ID: 18417739
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J
Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822
[TBL] [Abstract][Full Text] [Related]
39. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
[TBL] [Abstract][Full Text] [Related]
40. A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.
Warren K; Bent R; Wolters PL; Prager A; Hanson R; Packer R; Shih J; Camphausen K
Cancer; 2012 Jul; 118(14):3607-13. PubMed ID: 22086404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
